The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...

Bengaluru: Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday. As part of the ...

Previous guidelines endorsed shots for adults at least 65 years of age, people with certain chronic health conditions ... and emerging entrants designed to provide broader protection. Merck, for ...

The expert panel also cited factors such as economic considerations, serotype coverage and health equity benefits to back its conclusion. Merck's Capvaxive gears up to challenge Pfizer's dominant ...

falling short of the Medical sector's loss of 4.16% and the S&P 500's gain of 2.76%. The investment community will be closely monitoring the performance of Merck in its forthcoming earnings report.

So what does iodine do that's so important? It's key for thyroid health. If you live in the U.S., it's unlikely that you're not getting enough iodine in your diet. But iodine deficiency is common ...

Gdansk: German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for $600 million, it said ahead of its ...

Merck’s investigational antibody clesrovimab demonstrated more than 60% effectiveness in reducing some types of respiratory syncytial virus-associated infections in infants, while Pfizer’s RSV vaccine ...

Oct 17 (Reuters) - (This Oct. 17 story has been corrected to say that the drug reduced some types of respiratory infection, not all, in the headline and paragraphs 1 and 2) Merck (MRK.N), opens ...